FGF1 and cancer: Interestingly, inhibition of the mTOR pathway, but not the PI3K pathway, in triple-negative breast cancer cells led to increased FGF1 and Notch1 expression, enhanced FGFR1 activation and the formation of a resistant cancer stem cell-like population [88].